Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Clear-cell metastatic renal cell carcinoma × Radiopharmaceuticals × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Clear-cell metastatic renal cell carcinoma 1

Interventions

Nivolumab 11 Ipilimumab 8 Sunitinib 6 Specimen Handling 6 pembrolizumab 5 cabozantinib 5 CTLA-4 Antigen 5 pazopanib 4 Magnetic Resonance Spectroscopy 4 Radiosurgery 3 Biopsy 3 Axitinib 3 Everolimus 2 Blood Specimen Collection 2 tivozanib 1 sitravatinib 1 lenvatinib 1 fludarabine 1 belzutifan 1 atezolizumab 1 aldesleukin 1 Zoledronic Acid 1 Tissue Banks 1 Selenomethionine 1 Radiotherapy 1 Radiopharmaceuticals 1 Pluvicto 1 Nephrectomy 1 Molecular Imaging 1 Metastasectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06059014 2025-02-24

PRadR

Centre Leon Berard

Phase 1/2 Suspended

Clear-cell metastatic renal cell carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡